11/14/2024
4:45 PM | Astria Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
4:46 PM | Astria Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
11:03 AM | Astria Therapeutics (Subject)
Vestal Point Capital, LP (Filed by)
| Form SC 13G | |
11/13/2024
3:01 PM | Astria Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
12:29 PM | Astria Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/08/2024
1:17 PM | Astria Therapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
11/04/2024
11:37 AM | Astria Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
|
11/04/2024
10:39 AM | Astria Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
10:39 AM | Astria Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/01/2024
3:05 PM | Astria Therapeutics (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
| Form SC 13G | |
10/24/2024
1:02 PM | Astria Therapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
08/12/2024
3:56 PM | Astria Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/10/2024
9:10 AM | Astria Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
04/22/2024
3:06 PM | Astria Therapeutics (Filer)
| Form DEF 14A | |
04/22/2024
3:08 PM | Astria Therapeutics (Filer)
| Form DEFA14A | |
04/22/2024
3:10 PM | Astria Therapeutics (Filer)
| Form ARS | |
04/09/2024
7:07 AM | Astria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2024
7:09 AM | AGARWAL SUNIL (Reporting)
Astria Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/09/2024
7:11 AM | AGARWAL SUNIL (Reporting)
Astria Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
6:37 AM | Astria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
7:19 AM | Astria Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
03/07/2024
11:29 AM | Astria Therapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
02/14/2024
2:48 PM | Astria Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
7:36 AM | Astria Therapeutics (Subject)
Deep Track Capital, LP (Filed by)
| Form SC 13G/A | |
02/09/2024
7:35 AM | Astria Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
01/31/2024
7:59 AM | Astria Therapeutics (Filer)
| Form 424B5 | |
01/31/2024
8:00 AM | Astria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2024
4:03 PM | Astria Therapeutics (Issuer)
Morabito Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
5:01 AM | Astria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2024
4:26 PM | Astria Therapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G | |
01/29/2024
3:39 PM | Astria Therapeutics (Subject)
Morabito Christopher (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
7:30 AM | Astria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
3:16 PM | Astria Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G | |
01/01/2024
11:15 PM | Astria Therapeutics (Filer)
| Form EFFECT | |
12/28/2023
1:09 PM | Astria Therapeutics (Filer)
| Form S-3/A | |
12/22/2023
1:51 PM | Astria Therapeutics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Perceptive Xontogeny Venture Fund, LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:30 PM | Astria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2023
7:30 AM | Astria Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
